Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Prospective Study of Restless Legs Patients Switched to Ropinirole From Pramipexole to Help Determine the Equipotent Dose

NCT00344994 is registered in ClinicalTrials.gov with Augusta University as lead sponsor.

NCT NCT00344994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00344994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Prospective Study of Restless Legs Patients Switched to Ropinirole From Pramipexole to Help Determine the Equipotent Dose
Lead sponsor
Augusta University
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2006
Completion date
April 30, 2010
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome